Partner Content Partner Content Driving Patient Engagement Through Powerful Social Strategie... SMi’s Social Media in Pharma
Partner Content Partner Content Have you seen the agenda for Social Media in Pharma? Updates on Social Media in Pharma
Partner Content Partner Content Updates in Cutting Edge Lyophilization Technology Latest Updated for Lyophilization USA
Partner Content Partner Content Spotlight on Key Sessions You Cannot Miss at Ophthalmic Drug... Are you aware the ophthalmic market is expected to reach $21 billion by the year 2022?
Partner Content Partner Content 7 Key Reasons to Attend Social Media in the Pharmaceutical I... SMi's 10th Annual Conference
Partner Content Partner Content Introducing the 10th Annual Social Media in the Pharmaceutic... SMi's 10th Annual Social Media in Pharma
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
